Filter
4758
Filtered Results: 4758
Text search:
National
laboratory
system
Featured
Recommendations
477
New Publications
1367
Language
Document type
No document type
2638
Guidelines
823
Studies & Reports
664
Manuals
241
Strategic & Response Plan
231
Training Material
55
Fact sheets
47
Situation Updates
45
Brochures
5
Infographics
4
Resource Platforms
3
App
1
Videos
1
Countries / Regions
India
260
Kenya
139
Global
131
Sierra Leone
123
Liberia
113
Ethiopia
109
Latin America and the Carribbean
105
South Africa
101
Western and Central Europe
100
Nigeria
93
Uganda
89
Africa
83
Tanzania
82
Nepal
75
Rwanda
73
Zambia
71
Paraguay
67
Ghana
64
Malawi
64
Colombia
61
Bangladesh
53
Congo, Democratic Republic of
48
Eastern Europe
46
Argentina
44
Namibia
38
Bolivia
38
Myanmar / Burma
37
Guinea
36
Zimbabwe
36
Philippines
36
Venezuela
36
Syria
34
Senegal
32
Mozambique
32
Peru
31
East and Southern Africa
31
West and Central Africa
31
Brazil
30
Lesotho
30
Ukraine
29
South–East Asia Region
28
Ecuador
27
Cambodia
26
Chile
25
Haiti
23
Botswana
23
El Salvador
22
Asia
20
Burkina Faso
19
Middle East and North Africa
18
Indonesia
17
Eastern Europe and Central Asia
16
Pakistan
15
Eswatini/ Swaziland
15
Angola
15
Madagascar
15
Cameroon
13
South Sudan
13
Germany
13
Russia
12
USA
11
Western Pacific Region
10
Spain
10
Mali
9
Benin
9
Yemen
9
Thailand
8
Albania
8
Somalia
7
Afghanistan
7
Honduras
7
Tajikistan
7
Togo
6
Moldova
6
Georgia
6
Iraq
5
Papua New Guinea
5
Sudan
5
Central African Republic
5
North Macedonia
5
Guatemala
5
Mexico
5
Guinea-Bissau
4
Côte d’Ivoire / Ivory Coast
4
Jordan
4
Lebanon
4
Dominican Republic
4
Burundi
4
Nicaragua
4
Armenia
4
Uruguay
4
Saudi Arabia
3
Chad
3
China
3
Poland
3
Palestine
3
Southern Africa
3
Laos
3
Timor Leste/ East Timor
3
Iran
3
Vietnam
3
North America
3
Jamaica
3
Portugal
3
Turkey
2
Gambia
2
Hungary
2
Libya
2
Sri Lanka
2
Fiji
2
Bhutan
2
Qatar
2
Bulgaria
2
Romania
2
Turkmenistan
2
Japan
2
Mauritius
2
Tunisia
2
United Kingdom
2
Bosnia and Herzegovina
2
Morocco
1
Egypt
1
Mauritania
1
Switzerland
1
Serbia
1
Cuba
1
Greece
1
Italy
1
Djibouti
1
Mongolia
1
Canada
1
Estonia
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Gabon
1
Denmark
1
France
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
2156
Clinical Guidelines
444
Public Health
228
Key Resources
160
Women & Child Health
127
Pharmacy & Technologies
108
Capacity Building
63
Toolboxes
COVID-19
490
TB
478
HIV
336
Rapid Response
258
AMR
252
Ebola
171
NTDs
138
Pharmacy
124
Mental Health
118
Planetary Health
92
Caregiver
88
Conflict
66
Zika
54
NCDs
46
Cholera
43
Refugee
40
Polio
36
Specific Hazards
34
Natural Hazards
31
Global Health Education
26
Health Financing Toolbox
22
Disability
19
Social Ethics
3
Typhoon
1
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades....
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care ...s throughout the Region. Though there is no unified consensus on the best measures to use for the public’s health and a nation’s epidemiologic situation, it is common for the disease burden to be measured by disease rates (incidence, prevalence, etc.), disease-specific death rates, comparative morbidity and mortality rates, geographic distribution, and disability-adjusted life years (DALYs). The current epidemiological situation, including data on disease rates or geographic distribution for the diseases in Table 1, is discussed below in Section 4. Hotez et al. (2008) were the first to review and compare the burden of DALYs in Latin America and the Caribbean—for NTDs, HIV/AIDS, malaria, and TB—as it existed about 10 years ago. Though the regional burden of TB, malaria, and neglected infectious diseases (NIDs) is somewhat less than it was 10 years ago, work (and schooling) continue to be lost to illness and premature death or disability, and the need for stepping up disease elimination efforts is evident in all communities living in vulnerable conditions....
Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and
death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas disease transmission is also expected over the next several decades under climate chan...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
This publication is part of WHO 75th anniversary and aims to capture key successes in public health globally and in Namibia. It includes contributory messages from the Head of State, Prime Minister and the Minister of Health and Social Services.
The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. The annual report provides an overview of the use and impact of the Fund over the previous year.
This report is the annual global monitoring report documenting progress towards Sustainable Development Goal (SDG) 2 targets 2.1 and 2.2. This year’s report explores the links between urbanization and changing food systems and how these changes ar...
The COVID-19 pandemic has resulted in a double shock - health and economic. As of March 1, 2021, COVID-19 has cost more than 2.5 million lives and triggered an economic recession surpassing any economic downturn since World War II.
Part I of this paper explores the impact of this current macro-fisc...
The 2021 Global monitoring report on financial protection in health shows that before the COVID-19 pandemic, the world was off-track to reduce financial hardship due to health expenditures because trends in catastrophic health spending were going in the wrong direction and the number of people incur...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
